Apogee Therapeutics Inc

APGE

Company Profile

  • Business description

    Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.

  • Contact

    221 Crescent Street
    Building 17, Suite 102b
    WalthamMA02453
    USA

    T: +1 650 394-5230

    https://www.apogeetherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    91

Stocks News & Analysis

stocks

Signs of a turnaround for undervalued ASX share

Market likes the payoff from early efforts at reining in costs.
stocks

Australia has the highest dividend yields in the world, so why the endless chase for even higher yields?

Ashley Owen explores why investors' insatiable thirst for higher yields leads to unnecessarily complicating their portfolio.
stocks

Investing in gold miners

Exploring the commodity as prices continue to soar. 

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,825.1020.900.24%
CAC 408,178.5414.430.18%
DAX 4022,513.4298.60-0.44%
Dow JONES (US)44,579.30132.13-0.30%
FTSE 1008,732.4632.26-0.37%
HKSE22,620.33805.963.69%
NASDAQ19,944.561.08-0.01%
Nikkei 22539,149.43312.04-0.79%
NZX 50 Index12,989.1883.200.64%
S&P 5006,109.295.78-0.09%
S&P/ASX 2008,555.8015.800.19%
SSE Composite Index3,346.7214.240.43%

Market Movers